<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03176017</url>
  </required_header>
  <id_info>
    <org_study_id>HoLES-TUIP</org_study_id>
    <nct_id>NCT03176017</nct_id>
  </id_info>
  <brief_title>Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP</brief_title>
  <official_title>Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, Investigators planned to compare ejaculatory sparing and non-ejaculatory&#xD;
      sparing (conventional) TUIP using both subjective and objective assessment tools for the&#xD;
      degree of deobstruction.&#xD;
&#xD;
      Furthermore, the impact of both techniques on ejaculation and its secondary effect on orgasm&#xD;
      perception and different domains of sexual function will be thoroughly assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>impact on ejaculatory function and subsequently the impact of reported ejaculatory changes on orgasm perception</measure>
    <time_frame>1 year</time_frame>
    <description>Ejaculatory domain of Male sexual health questionnaire (Ej-MSHQ)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Erectile function domains (erectile function, orgasm, desire, intercourse satisfaction and overall satisfaction)</measure>
    <time_frame>1 year</time_frame>
    <description>International index of erectile function-15 (IIEF-15) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported functional urinary outcomes</measure>
    <time_frame>1 year</time_frame>
    <description>International prostate symptom score (IPSS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximum flow rate (Q.max)</measure>
    <time_frame>1 year</time_frame>
    <description>milliliters per second.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Prostate Hyperplasia</condition>
  <condition>Transurethral Incision Of The Prostate</condition>
  <condition>Ejaculatory Dysfunction</condition>
  <arm_group>
    <arm_group_label>Ejaculatory sparing TUIP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ejaculatory sparing TUIP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional TUIP</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>regular non ejaculatory sparing TUIP</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ejaculatory sparing TUIP</intervention_name>
    <description>The bladder neck will be incised and vaporized at the 5 or 7-o'clock position. The incision will start near the ureteral orifice and carry downward to about 0.5-1.0 cm proximal to the verumontanum</description>
    <arm_group_label>Ejaculatory sparing TUIP</arm_group_label>
    <other_name>ES-TUIP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional TUIP</intervention_name>
    <description>the bladder neck will be incised by Collins knife at the 5 or 7-o'clock position till the verumontanum.</description>
    <arm_group_label>Conventional TUIP</arm_group_label>
    <other_name>regular non ejaculatory sparing TUIP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American society of anesthesiologists (ASA) score ≤3.&#xD;
&#xD;
          -  TRUS estimated prostate weight ≤ 35 grams.&#xD;
&#xD;
          -  Sexually interested and having continuous relationship with the same partner&#xD;
             (interested).&#xD;
&#xD;
          -  Bladder outlet obstruction index (BOOI ) ≥ 20 as per pressure flow study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperative sexual or ejaculatory disturbances or pelvic pain syndrome&#xD;
&#xD;
          -  Neurological disorders that can affect potency and ejaculation e.g. long standing&#xD;
             uncontrolled diabetes mellitus (DM) type 2 (&gt; 10 years), DM type 1, cerebral stroke,&#xD;
             Parkinsonism&#xD;
&#xD;
          -  Urodynamic changes consistent with urethropathy or detrusor hypocontractility&#xD;
&#xD;
          -  Previous pelvic surgeries or radiotherapy&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M Shoma, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Urology and Nephrology center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nasr Eltabey, MD</last_name>
    <role>Study Director</role>
    <affiliation>Urology and Nephrology center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed N Elshal, MD</last_name>
    <role>Study Director</role>
    <affiliation>Urology and Nephrology center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahmoud Laimon, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology and Nephrology center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Elkashef</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abdelwahab R. Hashem, Msc</last_name>
    <phone>01069678979</phone>
    <phone_ext>002</phone_ext>
    <email>abdelwahab_hashem@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Alhussein, MBBCH</last_name>
    <phone>00201009074121</phone>
    <email>ahmedalhussein20@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <state>Aldakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdelwahab R. Hashem, Msc</last_name>
      <phone>00201069678979</phone>
      <email>abdelwahab_hashem@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Ahmed M Elshal, MD</last_name>
      <phone>+20502202222</phone>
      <phone_ext>1643</phone_ext>
      <email>elshalam@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 29, 2017</study_first_submitted>
  <study_first_submitted_qc>June 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2017</study_first_posted>
  <last_update_submitted>December 5, 2020</last_update_submitted>
  <last_update_submitted_qc>December 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Abdelwahab Hashem</investigator_full_name>
    <investigator_title>Urology Msc, Oncology fellow at Urology and Nephrology Center, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Transurethral Incision Of The Prostate</keyword>
  <keyword>Prostate</keyword>
  <keyword>Ejaculatory Sparing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Yes meta-analyses by contact the Dr Ahmed Elshal, MD (Study Chair)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

